Ausgabe 3/2021
Inhalt (30 Artikel)
Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis
Miao Liu, Fei Xie, Miaoyu Liu, Yi Zhang, Shu Wang
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy
Kate R. Pawloski, Audree B. Tadros, Varadan Sevilimedu, Ashley Newman, Lori Gentile, Emily C. Zabor, Monica Morrow, Kimberly J. Van Zee, Laurie J. Kirstein
Covid-19 related oncologist’s concerns about breast cancer treatment delays and physician well-being (the CROWN study)
Katharine A. Yao, Deanna Attai, Richard Bleicher, Kristine Kuchta, Meena Moran, Judy Boughey, Lee G. Wilke, Jill R. Dietz, Randy Stevens, Catherine Pesce, Katherine Kopkash, Scott Kurtzman, Terry Sarantou, David Victorson
Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration
Rupa Guha, Binbin Yue, Jianping Dong, Aditi Banerjee, Ginette Serrero
Prognostic significance of phosphoglycerate dehydrogenase in breast cancer
Muthukrishnan Chandrika, Pei Jou Chua, Umamaheswari Muniasamy, Ruby Yun Ju Huang, Aye Aye Thike, Cheng Teng Ng, Puay Hoon Tan, George W. Yip, Boon Huat Bay
Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer
Yihong Wang, Kamaljeet Singh, Don Dizon, Teresa Graves, Ali Amin, Evgeny Yakirevich
Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq
Lilibeth Lanceta, Nadiia Lypova, Conor O’Neill, Xiaohong Li, Eric Rouchka, Jason Chesney, Yoannis Imbert-Fernandez
Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients
Jieqiong Liu, Ying Li, Qian Li, Dandan Liang, Quanren Wang, Qiang Liu
Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
B. B. M. Suelmann, C. van Dooijeweert, E. van der Wall, S. Linn, P. J. van Diest
Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients
Leticia Aptecar, Frederic Fiteni, Marta Jarlier, Stephanie Delaine, Violaine Guillerme, William Jacot, Veronique D’Hondt
Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results
A. Coolbrandt, A. T’Jonck, K. Blauwens, E. Dejaeger, P. Neven, K. Punie, K. Vancoille, H. Wildiers
The INTEND 1 randomized controlled trial of duct endoscopy as an indicator of margin excision in breast conservation surgery
Gerald Gui, Effrosyni Panopoulou, Sarah Tang, Dominique Twelves, Mohammed Kabir, Ann Ward, Catherine Montgomery, Ashutosh Nerurkar, Peter Osin, Clare M. Isacke
Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan
Takaaki Konishi, Michimasa Fujiogi, Nobuaki Michihata, Kojiro Morita, Hiroki Matsui, Kiyohide Fushimi, Masahiko Tanabe, Yasuyuki Seto, Hideo Yasunaga
Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers
Sabine Grill, Maryam Yahiaoui-Doktor, Maryam Basrai, Joachim Struck, Janin Schulte, Anika Berling-Ernst, Christoph Engel, Mirjam Ullrich, Jacqueline Lammert, Stephan C. Bischoff, Thorsten Schmidt, Uwe Niederberger, Dimitrios Chronas, Kerstin Rhiem, Rita Schmutzler, Martin Halle, Marion Kiechle
Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
Leonardo Roberto da Silva, Camila Annicchino de Andrade, Fabrício Brenelli, Susana Ramalho, Tomás Reinert, Alessandra Borba Anton de Souza, Ana Elisa Ribeiro da Silva, Maria Beatriz de Paula Leite Kraft, Vivian Castro Antunes de Vasconcelos, Antônio Luiz Frasson, Renato Zochio Torresan, Cesar Cabello, Matthew J. Ellis, Luiz Carlos Zeferino
Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing
W. Iris Zhi, Raymond E. Baser, Alice Kwon, Connie Chen, Susan Qing Li, Lauren Piulson, Christina Seluzicki, Katherine S. Panageas, Steven E. Harte, Jun J. Mao, Ting Bao
Association between lincRNA expression and overall survival for patients with triple-negative breast cancer
Jie Ping, Shuya Huang, Jie Wu, Pingping Bao, Timothy Su, Kai Gu, Hui Cai, Xingyi Guo, Loren Lipworth, William J. Blot, Wei Zheng, Qiuyin Cai, Xiao-Ou Shu
Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study
Aglaia Schiza, Davide Mauri, Irma Fredriksson, Anna-Karin Wennstig, Antonios Valachis
Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II
Mia M. Gaudet, Emily Deubler, W. Ryan Diver, Samantha Puvanesarajah, Alpa V. Patel, Ted Gansler, Mark E. Sherman, Susan M. Gapstur
Similar rates of residual disease in patients with DCIS within 2 mm of lumpectomy margin regardless of the presence of invasive carcinoma
Bridget N. Kelly, Olga Kantor, Rong Tang, Suzanne B. Coopey, Barbara L. Smith, Conor R. Lanahan, Jenna E. Korotkin, Michelle C. Specht
Tumor phenotype and concordance in synchronous bilateral breast cancer in young women
Linda M. Pak, Rachel Gaither, Shoshana M. Rosenberg, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Craig Snow, Laura C. Collins, Tari A. King, Ann H. Partridge
Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women
Taruna Rajagopal, Arun Seshachalam, Krishna Kumar Rathnam, Arunachalam Jothi, Srikanth Talluri, Sivaramakrishnan Venkatabalasubramanian, Nageswara Rao Dunna
BRCA testing and outcomes in women with breast cancer
David D. Stenehjem, Claire Telford, Sudhir K. Unni, Hillevi Bauer, Amy Sainski, Rishi Deka, Marisa B. Schauerhamer, Xiangyang Ye, Casey R. Tak, Junjie Ma, Tapashi B. Dalvi, Lia Gutierrez, James A. Kaye, Jerzy E. Tyczynski, Diana I. Brixner, Joseph E. Biskupiak
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
N. I. Bouwer, T. G. Steenbruggen, J. van Rosmalen, H. N. Rier, J. J. E. M. Kitzen, M. L. van Bekkum, A. J. Ten Tije, P. C. de Jong, J. C. Drooger, C. Holterhues, C. H. Smorenburg, M. J. M. Kofflard, E. Boersma, G. S. Sonke, M.-D. Levin, A. Jager
Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer
M. Moossdorff, Marissa L. G. Vane, T. J. A. van Nijnatten, M. C. van Maaren, B. Goorts, E. M. Heuts, L. J. A. Strobbe, M. L. Smidt
Outcomes of systemic therapy in metastatic phyllodes tumor of the breast
Amanda Parkes, Wei-Lien Wang, Shreyaskumar Patel, Cheuk Hong Leung, Heather Lin, Anthony P. Conley, Neeta Somaiah, Dejka M. Araujo, Maria Zarzour, John Andrew Livingston, Joseph Ludwig, Christina L. Roland, Vinod Ravi, Robert S. Benjamin, Ravin Ratan
Activity of novel anti-HER2 agents for breast cancer based on hormone receptors expression
Paolo Tarantino, Giuseppe Curigliano
Octopus anastomosis: selection of anastomotic configuration in lymphaticovenular anastomosis according to vessels’ conditions
Tomohiro Kojimahara, Takashi Kageyama